Intelligent ICU of the Future

Sponsor
University of Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT03905668
Collaborator
National Institute for Biomedical Imaging and Bioengineering (NIBIB) (NIH), U.S. National Science Foundation (U.S. Fed), National Institutes of Health (NIH) (NIH)
200
1
81.9
2.4

Study Details

Study Description

Brief Summary

The objective of this project is to create deep learning and machine learning models capable of recognizing patient visual cues, including facial expressions such as pain and functional activity. Many important details related to the visual assessment of patients, such as facial expressions like pain, head and extremity movements, posture, and mobility are captured sporadically by overburdened nurses or are not captured at all. Consequently, these important visual cues, although associated with critical indices, such as physical functioning, pain, and impending clinical deterioration, often cannot be incorporated into clinical status. The study team will develop a sensing system to recognize facial and body movements as patient visual cues. As part of a secondary evaluation method the study team will assess the models ability to detect delirium.

Condition or Disease Intervention/Treatment Phase
  • Other: Video Monitoring
  • Other: Accelerometer Monitoring
  • Other: Electromyographic Monitoring
  • Other: Noise Level Monitoring
  • Other: Light Level Monitoring

Detailed Description

Pain is a critical national health problem with nearly 50% of critical care patients experience significant pain in the Intensive Care Unit (ICU). The under-assessment of pain response is one of the primary barriers to the adequate treatment of pain in critically ill patients, associated with many negative outcomes such as chronic pain after discharge, prolonged mechanical ventilation, longer ICU stay, and increased mortality risk. Nonetheless, many ICU patients are unable to self-report pain intensity due to clinical conditions, ventilation devices, and altered consciousness. Currently, behavioral pain scales are used to assess pain in nonverbal patients. Unfortunately, these scales require repetitive manual administration by overburdened nurses. Moreover, prior work suggests that nurses caring for quasi-sedated patients in critical care settings have considerable variability in pain intensity ratings. Furthermore, manual pain assessment tools lack the capability to monitor pain continuously and autonomously. Together, these challenges point to a critical need for developing objective and autonomous pain recognition systems.

Delirium is another common complication of hospitalization that poses significant health problems in hospitalized patients. It is most prevalent in surgical ICU patients with diagnosis rates up to 80%. It is characterized by changes in cognition, activity level, consciousness, and alertness. Delirium typically leads to changes in activity level and alertness that pose additional health risks including risk of fall, inadequate mobilization, disturbed sleep, inadequate pain control, and negative emotions. All of these effects are difficult to monitor in real-time and further contribute to worsening of patient's cognitive abilities, inhibit recovery, and slow down the rehabilitation process. Though about a third of delirium cases can benefit from intervention, detecting and predicting delirium is still very limited in practice. Current Delirium assessments need to be performed by trained healthcare staff, are time consuming, and resource intensive. Due to the resources necessary to complete the assessment, delirium is often assessed twice per day, despite the transient nature of the disease state which can come and go undetected between the assessments. Jointly these obstacles demonstrate a dire need for real-time autonomous delirium detection.

The investigators hypothesize that the proposed model would be able to leverage accelerometer, electromyographic, and video data for the purpose of autonomously quantifying patient facial expressions such as pain, characterizing functional activities, and delirium status. Rationalizing that autonomous visual cue quantification and delirium detection can reduce nurse workload and can enable real-time pain and delirium monitoring. Early detection of delirium offers patients the best chance for good delirium treatment outcomes.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Title:Intelligent ICU of the Future -Subtitle 1: Autonomous Pain Recognition in Non-Verbal and Critically Ill Patients -Subtitle 2: Fundamental Intelligent Building Blocks of the Intensive Care Unit (ICU) of the Future -Subtitle 3: Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making -Subtitle 4: ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
Actual Study Start Date :
Feb 3, 2016
Anticipated Primary Completion Date :
Nov 30, 2022
Anticipated Study Completion Date :
Nov 30, 2022

Arms and Interventions

Arm Intervention/Treatment
ICU Patients

Adults in admitted to an ICU at University of Florida Health Gainesville with an expected length of stay greater than 24 hours which are not on any form of contact precaution or isolation. Patients will have continuous video, accelerometer, and electromyographic monitoring for up to seven days while in the ICU.

Other: Video Monitoring
Patients may have video monitoring for up to seven days while in the ICU. The video system will be placed in an unobtrusive area in the patient's ICU room.

Other: Accelerometer Monitoring
Patients may have accelerometer monitoring for up to seven days while in the ICU. Commercially available accelerometer units, which have been validated in previous clinical studies, will be used.

Other: Electromyographic Monitoring
Patients may have electromyographic monitoring for up to seven days while in the ICU.
Other Names:
  • EMG monitoring
  • Other: Noise Level Monitoring
    Patients may have noise level monitoring (in decibels) for up to seven days while in the ICU.

    Other: Light Level Monitoring
    Patients may have light level monitoring for up to seven days while in the ICU.

    ICU Patient Friends/Family Members

    Adult visitors of participating ICU patients that are willing to provide feedback to the learning algorithms.

    Outcome Measures

    Primary Outcome Measures

    1. Defense Veterans Pain Reporting Scale (DVPRS) [Before hospital discharge, up to Day 8]

      Before discharge, patients will be shown three short video clips from their ICU admission and asked to rate their pain levels using the Defense Veterans Pain Reporting Scale. DVPRS is a 10 point visual scale used to self report pain (0-4 being mild pain; 5-7 being moderate pain; 8-10 being severe pain).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    ICU Patients:
    Inclusion Criteria:
    • patient admitted to University of Florida (UF) Health Gainesville ICU
    Exclusion Criteria:
    • Anticipated ICU stay is less than one day

    • Patient is on any form of contact precaution or isolation

    • Patient is unable to wear a Shimmer3 unit

    ICU Patient Friends/Family:
    Inclusion Criteria:
    • Individual has their name designated on a patient's informed consent form giving them permission to view and modify facial and activity data collected about that patient
    Exclusion Criteria:
    • Age < 18

    • They are unable to answer short questions on a touch screen display

    • They are unable to wear a proximity sensor

    • They were not on the listed of designated individuals specified in their friend/family members informed consent form

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UF Health Shands Hospital Gainesville Florida United States 32608

    Sponsors and Collaborators

    • University of Florida
    • National Institute for Biomedical Imaging and Bioengineering (NIBIB)
    • U.S. National Science Foundation
    • National Institutes of Health (NIH)

    Investigators

    • Principal Investigator: Azra Bihorac, MD, University of Florida

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Florida
    ClinicalTrials.gov Identifier:
    NCT03905668
    Other Study ID Numbers:
    • IRB201900354 -N
    • 1R21EB027344-01
    • 1750192
    • OCR20330
    • R01NS120924-01
    First Posted:
    Apr 5, 2019
    Last Update Posted:
    Oct 15, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 15, 2021